Dr. Peter E. Schwartz was the first Director of the Division of Gynecologic Oncology at Yale University which he established in 1979 and he was responsible for creating the Fellowship Training Program in 1980. Dr. Schwartz has an extremely active clinical practice in Gynecologic Oncology and participates in gynecologic oncology research. His research has included the identification of estrogen and progestin receptors in ovarian cancer, which led to the first clinical trial using anti–estrogens for management of women with advanced or recurrent ovarian cancer. Dr. Schwartz has been one of the leaders in the field for the management of the rare germ cell ovarian malignancies. Dr. Schwartz’s major clinical cancer activities have focused on the management of the common ovarian cancers and giving chemotherapy before surgery to women with extremely advanced ovarian cancers. He established the Yale Early Detection Program for Ovarian Cancer in 1990. Dr. Schwartz has been very active in developing therapies for the clinical management of uncommon forms of uterine cancer. He has published over 190 articles in peer reviewed medical journals and over 100 reviews, chapter and editorials in medical journals. He currently serves on the editorial boards of six medical journals. Dr. Schwartz has been President of the New Haven Obstetrics and Gynecology Society, the New England Association of Gynecologic Oncologists and the Society of Gynecologic Oncologists.

Dan–Arin Silasi, MD has joined the faculty of the Section of Gynecologic Oncology in the Department of Obstetrics, Gynecology & Reproductive Sciences as Assistant Professor as of July 2008. Dan first came to New Haven as a fellow in Gynecologic Oncology in 2005. Dan graduated summa cum laude from the University of Medicine and Pharmacy in Romania and trained in Otolaryngology. In the United States he trained in Internal Medicine at New York University, followed by residency in Obstetrics and Gynecology at the University of Texas in San Antonio and a fellowship in Gynecologic Oncology at Yale University. He received the José Asis Memorial Award while a Yale Fellow. During fellowship, he began research into mechanisms of chemoresistance in ovarian cancer under the guidance of Gil Mor, MD, PhD.

Dan has multiple original research peer–reviewed publications. Dan’s clinical interests include all gynecologic malignancies, and he has a particular interest in robotic surgery. Dr. Silasi is available for appointments immediately at the Yale Gynecologic Oncology New Haven office at 800 Howard Ave, and at the Bridgeport Hospital office.